ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,000 shares of the firm's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $19.85, for a total transaction of $39,700.00. Following the sale, the chief executive officer directly owned 152,500 shares in the company, valued at approximately $3,027,125. The trade was a 1.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
ReposiTrak Price Performance
NYSE TRAK traded up $0.10 on Tuesday, reaching $19.64. 53,882 shares of the stock were exchanged, compared to its average volume of 61,887. ReposiTrak Inc. has a one year low of $15.72 and a one year high of $25.01. The stock has a market cap of $359.02 million, a price-to-earnings ratio of 57.47 and a beta of 0.51. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01.
ReposiTrak Cuts Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, August 14th. Investors of record on Monday, June 30th will be given a dividend of $0.0182 per share. The ex-dividend date is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.37%. ReposiTrak's dividend payout ratio is 20.59%.
Hedge Funds Weigh In On ReposiTrak
A hedge fund recently raised its stake in ReposiTrak stock. Ellsworth Advisors LLC raised its holdings in shares of ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,289 shares of the company's stock after purchasing an additional 2,997 shares during the quarter. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 as of its most recent filing with the Securities & Exchange Commission. 27.35% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
View Our Latest Report on ReposiTrak
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
